Clinical Trial Update: Add-On Study of MSI-195 (S-Adenosyl-L-Methionine, SAMe) for Patients With Major Depressive Disorder (MDD) [Phase 2]

View source ↗

Summary

A Phase 2 add-on trial of MSI-195 (S-adenosyl-L-methionine) for Major Depressive Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• MSI-195 (S-adenosyl-L-methionine, SAMe) (S-adenosyl-L-methionine)

Snippet

Sponsor: MSI Methylation Sciences, Inc. | Conditions: Major Depressive Disorder (MDD) | Phase 2 | Status: COMPLETED